Barrow, Hanley, Mewhinney & Strauss
QDEL icon

Barrow, Hanley, Mewhinney & Strauss’s QuidelOrtho QDEL Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Hold
78
– – ﹤0.01% 351
2025
Q4 		$2.23K Hold
78
– – ﹤0.01% 311
2025
Q3 		$2.3K Buy
+78
New +$2.13K ﹤0.01% 311
2022
Q1 		– Sell
-493,958
Closed -$66.7M – 335
2021
Q4 		$66.7M Buy
493,958
+13,427
+3% +$1.87M 0.21% 97
2021
Q3 		$67.8M Buy
+480,531
New +$64.6M 0.22% 89

Other funds holding QDEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's QDEL Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss held its QuidelOrtho (QDEL) position steady in Q1 2026 at 78 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Barrow, Hanley, Mewhinney & Strauss first reported a position in QDEL in Q3 2021 and has held it in 5 quarters since. The position peaked at $67.8M in Q3 2021. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 78 shares of QuidelOrtho worth $1.28K as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss left its QuidelOrtho share count unchanged in Q1 2026.
  • QuidelOrtho made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #351 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in QuidelOrtho in Q3 2021 and has held it in 5 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's QuidelOrtho position peaked at $67.8M in Q3 2021.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.